Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

These are stage4 patients who have not responded and have failed multiple other drugs which brought them to the Dana Farber cancer research study, patients if not for the Kevetrin study would have no hope.

Hearing first hand of such a great improvement in the health and quality of life for this once very sick Ovarian cancer patient said to be well enough now to explore further treatment is simply remarkable. More to come I'm pretty sure.